Evidence map›Paper›PMID 36769410›Full record

ReviewJournal of clinical medicine2023

Cognitive Deficits in the Acute Phase of COVID-19: A Review and Meta-Analysis.

Isabele Jacot de Alcântara, Anthony Nuber-Champier, Philippe Voruz, Alexandre Cionca, Frederic Assal, Julie A Péron

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Effects of COVID-19 on cognition and brain health.Trends in cognitive sciences · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Isabele Jacot de AlcântaraClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, 1205 Geneva, Switzerland.
Anthony Nuber-ChampierClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, 1205 Geneva, Switzerland.ORCID 0000-0002-3736-6001
Philippe VoruzClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, 1205 Geneva, Switzerland.
Alexandre CioncaClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, 1205 Geneva, Switzerland.ORCID 0000-0002-1910-9650
Frederic AssalFaculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.
Julie A PéronClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, 1205 Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This meta-analysis was conducted to quantify the risk of patients exhibiting cognitive deficits in the acute phase of COVID-19 at the time of the first variants (i.e., before the vaccine) and quantify the potential vulnerability of older patients and those who experienced more severe respiratory symptoms. To this end, we searched the LitCovid and EMBASE platforms for articles, including preprints, and included all studies (

Indexed as

cognitionCOVID-19global scalesmeta-analysisreview

Identifiers

PMID36769410
PMCPMC9917639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.